SMAD3 and coronary artery disorder: According to the present findings, the rs17228212 polymorphism has no association with the risk of CAD (p-value = 1.0), which corresponds to that of Saleem Ullah Shahid et al. who reported no connection between rs17228212 in the SMAD3 gene and the risk of CAD [39].